Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) EPS (Basic) (2021 - 2025)

Historic EPS (Basic) for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to $1.77.

  • Krystal Biotech's EPS (Basic) rose 1132.08% to $1.77 in Q4 2025 from the same period last year, while for Dec 2025 it was $7.08, marking a year-over-year increase of 12765.27%. This contributed to the annual value of $7.08 for FY2025, which is 12692.31% up from last year.
  • As of Q4 2025, Krystal Biotech's EPS (Basic) stood at $1.77, which was up 1132.08% from $2.74 recorded in Q3 2025.
  • In the past 5 years, Krystal Biotech's EPS (Basic) ranged from a high of $2.88 in Q3 2023 and a low of -$1.99 during Q1 2022
  • Its 5-year average for EPS (Basic) is $0.09, with a median of -$0.34 in 2021.
  • Per our database at Business Quant, Krystal Biotech's EPS (Basic) crashed by 16885.03% in 2022 and then soared by 403333.33% in 2025.
  • Krystal Biotech's EPS (Basic) (Quarter) stood at -$0.95 in 2021, then tumbled by 31.58% to -$1.25 in 2022, then skyrocketed by 125.6% to $0.32 in 2023, then surged by 396.88% to $1.59 in 2024, then increased by 11.32% to $1.77 in 2025.
  • Its EPS (Basic) stands at $1.77 for Q4 2025, versus $2.74 for Q3 2025 and $1.33 for Q2 2025.